A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application

Cell Chemical Biology

Volumn 23, Issue 1, 2016, Pages 122-136

  Garland, Megan ^a   Yim, Joshua J ^a   Bogyo, Matthew ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; DNA PROBE; FIELD STUDY; FLUORESCENCE IMAGING; PERSONALIZED MEDICINE; SURGERY; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR LIBRARY; MOLECULAR MODEL; NEOPLASMS; PATHOLOGY; PHARMACOKINETICS; PROCEDURES;

CONTRAST MEDIUM; FLUORESCENT DYE; MOLECULAR LIBRARY; PEPTIDE;

ANIMALS; CONTRAST MEDIA; FLUORESCENT DYES; HUMANS; MODELS, MOLECULAR; NEOPLASMS; OPTICAL IMAGING; PEPTIDES; PRECISION MEDICINE; SMALL MOLECULE LIBRARIES;

EID: 84965082269     PISSN: 24519456     EISSN: 24519448     Source Type: Journal    
DOI: 10.1016/j.chembiol.2015.12.003     Document Type: Review

References (108)

1. M. Akcan, M.R. Stroud, S.J. Hansen, R.J. Clark, N.L. Daly, D.J. Craik, and J.M. Olson Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy J. Med. Chem. 54 2011 782 787
2. R. Andreesen, M. Modolell, H.U. Weltzien, H. Eibl, H.H. Common, G.W. Lohr, and P.G. Munder Selective destruction of human leukemic cells by alkyl-lysophospholipids Cancer Res. 38 1978 3894 3899
3. A.L. Antaris, H. Chen, K. Cheng, Y. Sun, G. Hong, C. Qu, S. Diao, Z. Deng, X. Hu, B. Zhang, and et al. A small-molecule dye for NIR-II imaging Nat. Mater. 2015 10.1038/nmat4476 in press. Published online November 23, 2015
4. A.C. Antony Folate receptors Annu. Rev. Nutr. 16 1996 501 521
5. T. Aoki, M. Murakami, D. Yasuda, Y. Shimizu, T. Kusano, K. Matsuda, T. Niiya, H. Kato, N. Murai, K. Otsuka, and et al. Intraoperative fluorescent imaging using indocyanine green for liver mapping and cholangiography J. Hepatobiliary Pancreat. Sci. 17 2010 590 594
6. D.H.S. Arora, M. Eneida, R. Abid, C. Ord, and E. Dauway Cost analysis of re-excisions for breast conserving surgery in Central Texas J. Clin. Oncol. 33 2015 e11534 2015 ASCO Annual Meeting
7. S.R. Banerjee, C.A. Foss, M. Castanares, R.C. Mease, Y. Byun, J.J. Fox, J. Hilton, S.E. Lupold, A.P. Kozikowski, and M.G. Pomper Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) J. Med. Chem. 51 2008 4504 4517
8. S.R. Banerjee, M. Pullambhatla, Y. Byun, S. Nimmagadda, C.A. Foss, G. Green, J.J. Fox, S.E. Lupold, R.C. Mease, and M.G. Pomper Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen Angew. Chem. Int. Ed. Engl. 50 2011 9167 9170
9. J.A. Barrett, R.E. Coleman, S.J. Goldsmith, S. Vallabhajosula, N.A. Petry, S. Cho, T. Armor, J.B. Stubbs, K.P. Maresca, M.G. Stabin, and et al. First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer J. Nucl. Med. 54 2013 380 387
10. G. Blum, S.R. Mullins, K. Keren, M. Fonovic, C. Jedeszko, M.J. Rice, B.F. Sloane, and M. Bogyo Dynamic imaging of protease activity with fluorescently quenched activity-based probes Nat. Chem. Biol. 1 2005 203 209
11. G. Blum, G. von Degenfeld, M.J. Merchant, H.M. Blau, and M. Bogyo Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes Nat. Chem. Biol. 3 2007 668 677
12. G. Blum, R.M. Weimer, L.E. Edgington, W. Adams, and M. Bogyo Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity PLoS One 4 2009 e6374
13. C. Bremer, C.H. Tung, and R. Weissleder In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7 2001 743 748
14. D.W.S. Bromme Role of cysteine cathepsins in extracellular proteolysis W.C.P.a.R.P. Mecham, Extracellular Matrix Degradation 2011 Springer Berlin Heidelberg 23 51
15. J.Q. Brown, T.M. Bydlon, S.A. Kennedy, M.L. Caldwell, J.E. Gallagher, M. Junker, L.G. Wilke, W.T. Barry, J. Geradts, and N. Ramanujam Optical spectral surveillance of breast tissue landscapes for detection of residual disease in breast tumor margins PLoS One 8 2013 e69906
16. N.C. Buchs, M.E. Hagen, F. Pugin, F. Volonte, P. Bucher, E. Schiffer, and P. Morel Intra-operative fluorescent cholangiography using indocyanin green during robotic single site cholecystectomy Int. J. Med. Robot. 8 2012 436 440
17. Centers for Disease Control and Prevention Number of All-listed Procedures for Discharges from Short-stay Hospitals, by Procedure Category and Age: United States, 2010 2012 CDC http://www.cdc.gov/nchs/data/nhds/4procedures/2010pro4-numberprocedureage.pdf
18. Y. Chen, S. Dhara, S.R. Banerjee, Y. Byun, M. Pullambhatla, R.C. Mease, and M.G. Pomper A low molecular weight PSMA-based fluorescent imaging agent for cancer Biochem. Biophys. Res. Commun. 390 2009 624 629
19. S.Y. Cho, K.L. Gage, R.C. Mease, S. Senthamizhchelvan, D.P. Holt, A. Jeffrey-Kwanisai, C.J. Endres, R.F. Dannals, G. Sgouros, M. Lodge, and et al. Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer J. Nucl. Med. 53 2012 1883 1891
20. H.S. Choi, S.L. Gibbs, J.H. Lee, S.H. Kim, Y. Ashitate, F. Liu, H. Hyun, G. Park, Y. Xie, S. Bae, and et al. Targeted zwitterionic near-infrared fluorophores for improved optical imaging Nat. Biotechnol. 31 2013 148 153
21. F.S. Collins, and H. Varmus A new initiative on precision medicine N. Engl. J. Med. 372 2015 793 795
22. J.L. Cutter, N.T. Cohen, J. Wang, A.E. Sloan, A.R. Cohen, A. Panneerselvam, M. Schluchter, G. Blum, M. Bogyo, and J.P. Basilion Topical application of activity-based probes for visualization of brain tumor tissue PLoS One 7 2012 e33060
23. J. Deshane, C.C. Garner, and H. Sontheimer Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 J. Biol. Chem. 278 2003 4135 4144
24. G. Destito, R. Yeh, C.S. Rae, M.G. Finn, and M. Manchester Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells Chem. Biol. 14 2007 1152 1162
25. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
26. L.E. Edgington, A.B. Berger, G. Blum, V.E. Albrow, M.G. Paulick, N. Lineberry, and M. Bogyo Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes Nat. Med. 15 2009 967 973
27. L.E. Edgington, M. Verdoes, A. Ortega, N.P. Withana, J. Lee, S. Syed, M.H. Bachmann, G. Blum, and M. Bogyo Functional imaging of legumain in cancer using a new quenched activity-based probe J. Am. Chem. Soc. 135 2013 174 182
28. T. Fujii, M. Kamiya, and Y. Urano In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins Bioconjug. Chem. 25 2014 1838 1846
29. S.C. Gribar, and G.G. Hamad Ischemic bowel after laparoscopic Roux-en-Y gastric bypass: limited resection based on fluorescein assessment of bowel viability Surg. Obes. Relat. Dis. 3 2007 561 563
30. S.J. Henley, S. Singh, J. King, R. Wilson, B. Ryerson, and Centers for Disease Control and Prevention Invasive cancer incidence - United States, 2010 MMWR Morb. Mortal. Wkly. Rep. 63 2014 253 259
31. N. Howlader, A.M. Noone, M. Krapcho, J. Garshell, D. Miller, S.F. Altekruse, C.L. Kosary, M. Yu, J. Ruhl, Z. Tatalovich, and et al. SEER Cancer Statistics Review, 1975-2012 2014 National Cancer Institute http://seer.cancer.gov/csr/1975-2012/
32. H.Y. Hu, D. Vats, M. Vizovisek, L. Kramer, C. Germanier, K.U. Wendt, M. Rudin, B. Turk, O. Plettenburg, and C. Schultz In vivo imaging of mouse tumors by a lipidated cathepsin S substrate Angew. Chem. Int. Ed. Engl. 53 2014 7669 7673
33. S.S. Huang, X. Wang, Y. Zhang, A. Doke, F.P. DiFilippo, and W.D. Heston Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker Prostate 74 2014 702 713
34. T.L. Huston, R. Pigalarga, M.P. Osborne, and E. Tousimis The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery Am. J. Surg. 192 2006 509 512
35. L. Jacobs Positive margins: the challenge continues for breast surgeons Ann. Surg. Oncol. 15 2008 1271 1272
36. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. USA 101 2004 17867 17872
37. M. Kamiya, D. Asanuma, E. Kuranaga, A. Takeishi, M. Sakabe, M. Miura, T. Nagano, and Y. Urano beta-Galactosidase fluorescence probe with improved cellular accumulation based on a spirocyclized rhodol scaffold J. Am. Chem. Soc. 133 2011 12960 12963
38. D.G. Kirsch, D.M. Dinulescu, J.B. Miller, J. Grimm, P.M. Santiago, N.P. Young, G.P. Nielsen, B.J. Quade, C.J. Chaber, C.P. Schultz, and et al. A spatially and temporally restricted mouse model of soft tissue sarcoma Nat. Med. 13 2007 992 997
39. A.P. Kozikowski, F. Nan, P. Conti, J. Zhang, E. Ramadan, T. Bzdega, B. Wroblewska, J.H. Neale, S. Pshenichkin, and J.T. Wroblewski Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase) J. Med. Chem. 44 2001 298 301
40. W.D. Lee, M.G. Bawendi, and J. Ferrer Imaging Agent for Detection of Diseased Cells 2014 Lumicell, Inc
41. H. Lepor A review of surgical techniques for radical prostatectomy Rev. Urol. 7 Suppl 2 2005 S11 S17
42. J.O. Link, and S. Zipfel Advances in cathepsin S inhibitor design Curr. Opin. Drug Discov. Devel. 9 2006 471 482
43. S.A. Lyons, J. O'Neal, and H. Sontheimer Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin Glia 39 2002 162 173
44. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
45. J.J. McGinty Jr., N. Hogle, and D.L. Fowler Laparoscopic evaluation of intestinal ischemia using fluorescein and ultraviolet light in a porcine model Surg. Endosc. 17 2003 1140 1143
46. R.C. Mease, C.L. Dusich, C.A. Foss, H.T. Ravert, R.F. Dannals, J. Seidel, A. Prideaux, J.J. Fox, G. Sgouros, A.P. Kozikowski, and et al. N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer Clin. Cancer Res. 14 2008 3036 3043
47. J.E. Mendez, W.W. Lamorte, A. de Las Morenas, S. Cerda, R. Pistey, T. King, M. Kavanah, E. Hirsch, and M.D. Stone Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma Am. J. Surg. 192 2006 538 540
48. M.M. Mohamed, and B.F. Sloane Cysteine cathepsins: multifunctional enzymes in cancer Nat. Rev. Cancer 6 2006 764 775
49. B.P. Neuman, J.B. Eifler, M. Castanares, W.H. Chowdhury, Y. Chen, R.C. Mease, R. Ma, A. Mukherjee, S.E. Lupold, M.G. Pomper, and et al. Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer Clin. Cancer Res. 21 2015 771 780
50. Q.T. Nguyen, and R.Y. Tsien Fluorescence-guided surgery with live molecular navigation-a new cutting edge Nat. Rev. Cancer 13 2013 653 662
51. Obama, B.H. (2015). 2015 State of the Union Address. https://www.whitehouse.gov/the-press-office/2015/01/20/remarks-president-state-union-address-january-20-2015.
52. L.O. Ofori, N.P. Withana, T.R. Prestwood, M. Verdoes, J.J. Brady, M.M. Winslow, J. Sorger, and M. Bogyo Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery ACS Chem. Biol. 10 2015 1977 1988
53. E.S. Olson, T.A. Aguilera, T. Jiang, L.G. Ellies, Q.T. Nguyen, E.H. Wong, L.A. Gross, and R.Y. Tsien In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer Integr. Biol. (Camb) 1 2009 382 393
54. K. Oresic Bender, L. Ofori, W.A. van der Linden, E.D. Mock, G.K. Datta, S. Chowdhury, H. Li, E. Segal, M. Sanchez Lopez, J.A. Ellman, and et al. Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization J. Am. Chem. Soc. 137 2015 4771 4777
55. R.K. Orosco, R.Y. Tsien, and Q.T. Nguyen Fluorescence imaging in surgery IEEE Rev. Biomed. Eng. 6 2013 178 187
56. D.J. O'Shannessy, G. Yu, R. Smale, Y.S. Fu, S. Singhal, R.P. Thiel, E.B. Somers, and A. Vachani Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance Oncotarget 3 2012 414 425
57. M.H. Park, H. Hyun, Y. Ashitate, H. Wada, G. Park, J.H. Lee, C. Njiojob, M. Henary, J.V. Frangioni, and H.S. Choi Prototype nerve-specific near-infrared fluorophores Theranostics 4 2014 823 833
58. N. Parker, M.J. Turk, E. Westrick, J.D. Lewis, P.S. Low, and C.P. Leamon Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 338 2005 284 293
59. A.N. Pinchuk, M.A. Rampy, M.A. Longino, R.W. Skinner, M.D. Gross, J.P. Weichert, and R.E. Counsell Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues J. Med. Chem. 49 2006 2155 2165
60. M.G. Pomper, J.L. Musachio, J. Zhang, U. Scheffel, Y. Zhou, J. Hilton, A. Maini, R.F. Dannals, D.F. Wong, and A.P. Kozikowski 11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase) Mol. Imaging 1 2002 96 101
61. J.C. Powers, J.L. Asgian, O.D. Ekici, and K.E. James Irreversible inhibitors of serine, cysteine, and threonine proteases Chem. Rev. 102 2002 4639 4750
62. H. Ra, E. Gonzalez-Gonzalez, M.J. Uddin, B.L. King, A. Lee, I. Ali-Khan, L.J. Marnett, J.Y. Tang, and C.H. Contag Detection of non-melanoma skin cancer by in vivo fluorescence imaging with fluorocoxib A Neoplasia 17 2015 201 207
63. E.L. Rosenthal, J.M. Warram, K.I. Bland, and K.R. Zinn The status of contemporary image-guided modalities in oncologic surgery Ann. Surg. 261 2015 46 55
64. E.L. Rosenthal, J.M. Warram, E. de Boer, J.P. Basilion, M.A. Biel, M. Bogyo, M. Bouvet, B.E. Brigman, Y.L. Colson, S.R. DeMeester, and et al. Successful translation of fluorescence navigation during oncologic surgery: a consensus report J. Nucl. Med. 2015 in press. Published online October 8, 2015. jnumed.115.158915
65. E.L. Rosenthal, J.M. Warram, E. de Boer, T.K. Chung, M.L. Korb, M. Brandwein-Gensler, T.V. Strong, C.E. Schmalbach, A.B. Morlandt, G. Agarwal, and et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck Cancer Clin. Cancer Res. 21 2015 3658 3666
66. S.P. Rowe, K.L. Gage, S.F. Faraj, K.J. Macura, T.C. Cornish, N. Gonzalez-Roibon, G. Guner, E. Munari, A.W. Partin, C.P. Pavlovich, and et al. (1)(8)F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer J. Nucl. Med. 56 2015 1003 1010
67. S.P. Rowe, K.J. Macura, A. Ciarallo, E. Mena, A. Blackford, R. Nadal, E. Antonarakis, M. Eisenberger, M. Carducci, A. Ross, and et al. Comparison of PSMA-based 18F-DCFBC PET/CT to conventional imaging modalities for detection of hormone-sensitive and castration-resistant metastatic prostate cancer J. Nucl. Med. 2015 in press. Published online October 22, 2015. jnumed.115.163782
68. M. Sakabe, D. Asanuma, M. Kamiya, R.J. Iwatate, K. Hanaoka, T. Terai, T. Nagano, and Y. Urano Rational design of highly sensitive fluorescence probes for protease and glycosidase based on precisely controlled spirocyclization J. Am. Chem. Soc. 135 2013 409 414
69. J.M. Saul, A. Annapragada, J.V. Natarajan, and R.V. Bellamkonda Controlled targeting of liposomal doxorubicin via the folate receptor in vitro J. Control Release 92 2003 49 67
70. E.N. Savariar, C.N. Felsen, N. Nashi, T. Jiang, L.G. Ellies, P. Steinbach, R.Y. Tsien, and Q.T. Nguyen Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides Cancer Res. 73 2013 855 864
71. R.M. Schols, N.D. Bouvy, R.M. van Dam, A.A. Masclee, C.H. Dejong, and L.P. Stassen Combined vascular and biliary fluorescence imaging in laparoscopic cholecystectomy Surg. Endosc. 27 2013 4511 4517
72. R.M. Schols, N.D. Bouvy, R.M. van Dam, and L.P. Stassen Advanced intraoperative imaging methods for laparoscopic anatomy navigation: an overview Surg. Endosc. 27 2013 1851 1859
73. N. Schulke, O.A. Varlamova, G.P. Donovan, D. Ma, J.P. Gardner, D.M. Morrissey, R.R. Arrigale, C. Zhan, A.J. Chodera, K.G. Surowitz, and et al. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy Proc. Natl. Acad. Sci. USA 100 2003 12590 12595
74. E. Segal, T.R. Prestwood, W.A. van der Linden, Y. Carmi, N. Bhattacharya, N. Withana, M. Verdoes, A. Habtezion, E.G. Engleman, and M. Bogyo Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins Chem. Biol. 22 2015 148 158
75. D.A. Sherwinter Identification of anomolous biliary anatomy using near-infrared cholangiography J. Gastrointest. Surg. 16 2012 1814 1815
76. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, T. Smith, D. Cooper, T. Gansler, C. Lerro, S. Fedewa, and et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J. Clin. 62 2012 220 241
77. F. Snyder, and R. Wood Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues Cancer Res. 29 1969 251 257
78. F. Snyder, M.L. Blank, and H.P. Morris Occurrence and nature of O-alkyl and O-alk-I-enyl moieties of glycerol in lipids of Morris transplanted hepatomas and normal rat liver Biochim. Biophys. Acta 176 1969 502 510
79. C. Sobolewski, C. Cerella, M. Dicato, L. Ghibelli, and M. Diederich The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies Int. J. Cell Biol. 2010 2010 215158
80. L. Soroceanu, Y. Gillespie, M.B. Khazaeli, and H. Sontheimer Use of chlorotoxin for targeting of primary brain tumors Cancer Res. 58 1998 4871 4879
81. M. Srinivasarao, C.V. Galliford, and P.S. Low Principles in the design of ligand-targeted cancer therapeutics and imaging agents Nat. Rev. Drug Discov. 14 2015 203 219
82. K.I. Swanson, P.A. Clark, R.R. Zhang, I.K. Kandela, M. Farhoud, J.P. Weichert, and J.S. Kuo Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection Neurosurgery 76 2015 115 123 discussion 123-4
83. Q.R. Tummers, M.C. Boonstra, J.V. Frangioni, C.J. van de Velde, A.L. Vahrmeijer, and B.A. Bonsing Intraoperative near-infrared fluorescence imaging of a paraganglioma using methylene blue: a case report Int. J. Surg. Case Rep. 6C 2015 150 153
84. M.J. Uddin, B.C. Crews, A.L. Blobaum, P.J. Kingsley, D.L. Gorden, J.O. McIntyre, L.M. Matrisian, K. Subbaramaiah, A.J. Dannenberg, D.W. Piston, and et al. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents Cancer Res. 70 2010 3618 3627
85. M.J. Uddin, B.C. Crews, K. Ghebreselasie, and L.J. Marnett Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents Bioconjug. Chem. 24 2013 712 723
86. H. Ueo, Y. Shinden, T. Tobo, A. Gamachi, M. Udo, H. Komatsu, S. Nambara, T. Saito, M. Ueda, H. Hirata, and et al. Rapid intraoperative visualization of breast lesions with gamma-glutamyl hydroxymethyl rhodamine green Sci. Rep. 5 2015 12080
87. Y. Urano, M. Sakabe, N. Kosaka, M. Ogawa, M. Mitsunaga, D. Asanuma, M. Kamiya, M.R. Young, T. Nagano, P.L. Choyke, and et al. Rapid cancer detection by topically spraying a gamma-glutamyltranspeptidase-activated fluorescent probe Sci. Transl. Med. 3 2011 110ra119
88. U.S. Cancer Statistics Working Group United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report 2015 U.S. Department of Health and Human Services; Centers for Disease Control and Prevention and National Cancer Institute http://www.cdc.gov/uscs
89. A.L. Vahrmeijer, M. Hutteman, J.R. van der Vorst, C.J. van de Velde, and J.V. Frangioni Image-guided cancer surgery using near-infrared fluorescence Nat. Rev. Clin. Oncol. 10 2013 507 518
90. W.J. van Blitterswijk, and M. Verheij Anticancer mechanisms and clinical application of alkylphospholipids Biochim. Biophys. Acta 1831 2013 663 674
91. G.M. van Dam, G. Themelis, L.M. Crane, N.J. Harlaar, R.G. Pleijhuis, W. Kelder, A. Sarantopoulos, J.S. de Jong, H.J. Arts, A.G. van der Zee, and et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results Nat. Med. 17 2011 1315 1319
92. M. Veiseh, P. Gabikian, S.B. Bahrami, O. Veiseh, M. Zhang, R.C. Hackman, A.C. Ravanpay, M.R. Stroud, Y. Kusuma, S.J. Hansen, and et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci Cancer Res. 67 2007 6882 6888
93. F.P. Verbeek, J.R. van der Vorst, B.E. Schaafsma, R.J. Swijnenburg, K.N. Gaarenstroom, H.W. Elzevier, C.J. van de Velde, J.V. Frangioni, and A.L. Vahrmeijer Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience J. Urol. 190 2013 574 579
94. F.P. Verbeek, B.E. Schaafsma, Q.R. Tummers, J.R. van der Vorst, W.J. van der Made, C.I. Baeten, B.A. Bonsing, J.V. Frangioni, C.J. van de Velde, A.L. Vahrmeijer, and et al. Optimization of near-infrared fluorescence cholangiography for open and laparoscopic surgery Surg. Endosc. 28 2014 1076 1082
95. F.P. Verbeek, J.R. van der Vorst, Q.R. Tummers, M.C. Boonstra, K.E. de Rooij, C.W. Lowik, A.R. Valentijn, C.J. van de Velde, H.S. Choi, J.V. Frangioni, and et al. Near-infrared fluorescence imaging of both colorectal cancer and ureters using a low-dose integrin targeted probe Ann. Surg. Oncol. 21 Suppl 4 2014 S528 S537
96. M. Verdoes, L.E. Edgington, F.A. Scheeren, M. Leyva, G. Blum, K. Weiskopf, M.H. Bachmann, J.A. Ellman, and M. Bogyo A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages Chem. Biol. 19 2012 619 628
97. M. Verdoes, K. Oresic Bender, E. Segal, W.A. van der Linden, S. Syed, N.P. Withana, L.E. Sanman, and M. Bogyo Improved quenched fluorescent probe for imaging of cysteine cathepsin activity J. Am. Chem. Soc. 135 2013 14726 14730
98. X. Wang, S.S. Huang, W.D. Heston, H. Guo, B.C. Wang, and J.P. Basilion Development of targeted near-infrared imaging agents for prostate cancer Mol. Cancer Ther. 13 2014 2595 2606
99. J.M. Warram, E. de Boer, A.G. Sorace, T.K. Chung, H. Kim, R.G. Pleijhuis, G.M. van Dam, and E.L. Rosenthal Antibody-based imaging strategies for cancer Cancer Metastasis Rev. 33 2014 809 822
100. A. Watzke, G. Kosec, M. Kindermann, V. Jeske, H.P. Nestler, V. Turk, B. Turk, and K.U. Wendt Selective activity-based probes for cysteine cathepsins Angew. Chem. Int. Ed. Engl. 47 2008 406 409
101. J.P. Weichert, P.A. Clark, I.K. Kandela, A.M. Vaccaro, W. Clarke, M.A. Longino, A.N. Pinchuk, M. Farhoud, K.I. Swanson, J.M. Floberg, and et al. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy Sci. Transl. Med. 6 2014 240ra275
102. R. Weissleder, C.H. Tung, U. Mahmood, and A. Bogdanov Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat. Biotechnol. 17 1999 375 378
103. S.D. Weitman, R.H. Lark, L.R. Coney, D.W. Fort, V. Frasca, V.R. Zurawski Jr., and B.A. Kamen Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues Cancer Res. 52 1992 3396 3401
104. M. Whitney, J.L. Crisp, E.S. Olson, T.A. Aguilera, L.A. Gross, L.G. Ellies, and R.Y. Tsien Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides J. Biol. Chem. 285 2010 22532 22541
105. M. Whitney, E.N. Savariar, B. Friedman, R.A. Levin, J.L. Crisp, H.L. Glasgow, R. Lefkowitz, S.R. Adams, P. Steinbach, N. Nashi, and et al. Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation Angew. Chem. Int. Ed. Engl. 52 2013 325 330
106. J. Yang, E. Vlashi, and P. Low Folate-linked drugs for the treatment of cancer and inflammatory diseases Subcell. Biochem. 56 2012 163 179
107. D. Ye, A.J. Shuhendler, L. Cui, L. Tong, S.S. Tee, G. Tikhomirov, D.W. Felsher, and J. Rao Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo Nat. Chem. 6 2014 519 526
108. M. Yoshida, K. Kubota, J. Kuroda, K. Ohta, T. Nakamura, J. Saito, M. Kobayashi, T. Sato, Y. Beck, Y. Kitagawa, and et al. Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted gastrectomy J. Gastroenterol. Hepatol. 27 Suppl 3 2012 29 33